Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Must Reads by Date

Must reads for theWeek ending March 26, 2017

Everolimus Evaluated for Indolent Non-Hodgkin Lymphomas, Am J Hematol; ePub 2017 Mar 10; Bennani, et al

More must reads

Must reads for theWeek ending January 29, 2017

FDA Approves Imbruvica for Marginal Zone Lymphoma, AbbVie news release; 2017 Jan 19

More must reads

Must reads for theWeek ending November 27, 2016

Bendamustine and Rituximab for Lymphoma Evaluated, Leuk Lymphoma; ePub 2016 Nov 14; Bond, et al

More must reads

Must reads for theWeek ending November 20, 2016

PET for Initial Staging of Follicular Lymphoma, Leuk Lymphoma; ePub 2016 Nov 10; Rai, et al

More must reads

Must reads for theWeek ending November 6, 2016

Primary Ocular Adnexal MALT Lymphoma Outcomes Studied, Blood; ePub 2016 Oct 27; Desai, Joag, et al

HIV Infection and Lymphoma Survival , Cancer Epidemiol Biomarkers Prev; ePub 2016 Oct 18; Han, et al

Allo-HCT Impact on Lymphoplasmacytic Lymphoma, Biol Blood Marrow Transplant; ePub 2016 Oct 24; Cornell, et al

More must reads

Pages